The SAPHO syndrome: A single-center study of 41 adult patients

Journal of Rheumatology

Volumn 42, Issue 2, 2015, Pages 329-334

  Aljuhani, Faisal ^a   Tournadre, Anne ^a   Tatar, Zuzana ^a   Couderc, Marion ^a   Mathieu, Sylvain ^a   Malochet Guinamand, Sandrine ^a   Soubrier, Martin ^a   Dubost, Jean Jacques ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Service de Rhumatologie   (France)

Author keywords

Bisphosphonate; Palmoplantar pustulosis; Sapho; Spondyloarthritis

Indexed keywords

ADALIMUMAB; AZITHROMYCIN; COLCHICINE; DOXYCYCLINE; ETANERCEPT; HLA B27 ANTIGEN; INFLIXIMAB; METHOTREXATE; PAMIDRONIC ACID; SALAZOSULFAPYRIDINE;

ACNE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE BIOPSY; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; KNEE ARTHRITIS; MALE; OSTEITIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUSTULOSIS PALMOPLANTARIS; RETROSPECTIVE STUDY; SACROILIAC JOINT; SAPHO SYNDROME; SPINE; THORAX WALL; VERY ELDERLY; ACQUIRED HYPEROSTOSIS SYNDROME; ARTHRITIS; COMPLICATION; MIDDLE AGED; YOUNG ADULT;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84923208740     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140342     Document Type: Article

References (26)

1. Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. [Article in French] Rev Rhum Mal Osteoartic 1987;54:187-96.
2. Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum 2012;42:254-65.
3. Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Sibermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999; 29:159-71.
4. Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009;61:813-21.
5. Sallés M, Olivé A, Perez-Andres R, Holgado S, Mateo L, Riera E, et al. The SAPHO syndrome: a clinical and imaging study. Clin Rheumatol 2011;30:245-9.
6. Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustu-losis-hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988;6:109-12.
7. Parlier-Cuau C, Laredo J. [Vertebral involvement in SAPHO syndrome]. [Article in French] J Radiol 2010;91:1068-78.
8. Mann B, Shaerf DA, Sheeraz A, Skinner JA, Saifuddin A. SAPHO syndrome presenting as widespread bony metastatic disease of unknown origin. Rheumatol Int 2012;32:505-7.
9. Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol 1994;8:333-62.
10. Hayem G. Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007;74:123-6.
11. Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis 1981;40:547-53.
12. Govoni M, Colina M, Massara A, Trotta F. "SAPHO syndrome and infections". Autoimmun Rev 2009;8:256-9.
13. Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009;11:R140.
14. Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesitis involvement. J Rheumatol 1995;22:2135-41.
15. Queiro R, Moreno P, Sarasqueta C, Alperi M, Riestra JL, Ballina J. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol 2008;26:125-8.
16. Grosjean C, Hurtado-Nedelec M, Nicaise-Roland P, Ferreyra-Dillon R, Bollet C, Quintin E, et al. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients. J Rheumatol 2010;37:639-43.
17. Carneiro S, Sampaio-Barros PD. SAPHO syndrome. Rheum Dis Clin N Am 2013;39:401-18.
18. Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002;69:392-6.
19. Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology 2004;43:658-61.
20. Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009;27:112-5.
21. Solau-Gervais E, Soubrier M, Gerot I, Grange L, Puechal X, Sordet C, et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology 2006;45:339-42.
22. Wagner AD, Andresen J, Jendro MC, Hülsemann JL, Zeidler H. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002;46:1965-8.
23. Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology 2010;49:1505-12.
24. Ben Abdelghani K, Dran DG, Gottenberg JE, Morel J, Sibilia J, Combe B. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 2010;37:1699-704.
25. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 2006;45:730-3.
26. Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis 2012;71:1098-100.